Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 3, 2013, Pages 447-450

  Vena, Gino A ^a   Cassano, Nicoletta ^a   Coco, Valeria ^b   De Simone, Clara ^b  

^a UNIVERSITY OF BARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antihypertensive drugs; Cutaneous adverse drug reactions; Drug induced dermatitis; Eczema; Hydrochlorothiazide

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; IRBESARTAN; LOSARTAN; OLMESARTAN; QUINAPRIL; RAMIPRIL; VALSARTAN;

AGED; ARTICLE; CLINICAL ARTICLE; DERMATITIS; ECZEMA; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MEDICAL RECORD REVIEW; OSTEOARTHRITIS; PRIORITY JOURNAL; RASH;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG ERUPTIONS; ECZEMA; FEMALE; HUMANS; MALE; MEDICAL RECORDS;

EID: 84877850376     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.797992     Document Type: Article

References (15)

1. Thestrup-Pedersen K. Adverse reactions in the skin from antihypertensive drugs. Dan Med Bull 1987;34:3-5
2. Steckelings UM, Artuc M, Wollschla?ger T, et al. Angiotensinconverting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta Derm Venereol 2001;81:321-325
3. Atzori L, Pinna AL, Ferreli C, Aste N. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Dermatol Online J 2006;12:1
4. Litt JZ. Litts drug eruption reference manual including drug interaction. 14th ed. London: Informa Healthcare; 2008
5. Vena GA, Cassano N. Toxic drug-induced chronic pruritus. Immunopharmacol Immunotoxicol 2012;34:1075-1076
6. Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol 1980;116:902-905
7. Wilkin JK, Kirkendall WM. Pityriasis rosea-like rash from captopril. Arch Dermatol 1982;118:186-187
8. Chalmers D, Whitehead A, Lawson DH. Postmarketing surveillance of captopril for hypertension. Br J Clin Pharmacol 1992;34: 215-223
9. Gambini D, Sala F, Gianotti R, Cusini M. Exanthematous reaction to irbesartan. J Eur Acad Dermatol Venereol 2003;17:472-473
10. Pfab F, Athanasiadis GI, Kollmar A, et al. Lichenoid drug eruption due to an antihypertonic drug containing irbesartan and hydrochlorothiazide. Allergy 2006;61:786-787
11. Ozturk G, Turk BG, Senturk B, et al. Exanthematous drug eruption due to valsartan. Cutan Ocul Toxicol 2013;32:41-45
12. Campbell DJ, Krum H, Esler MD. Losartan increases bradykinin levels in hypertensive humans. Circulation 2005;111:315-320
13. Landmesser U, Drexler H. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide. J Hypertens 2006;24:S39-S43
14. Battegay EJ, de Miguel LS, Petrimpol M, Humar R. Effects of antihypertensive drugs on vessel rarefaction. Curr Opin Pharmacol 2007;7:151-157
15. Steckelings UM, Wollschlager T, Peters J, et al. Human skin: source of and target organ for angiotensin II. Exp Dermatol 2004;13: 148-154